CIN 和 HR-HPV 治疗市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00029878
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 245
Buy Now

[调查报告]CIN & HR-HPV治疗市场规模预计将从2022年的116.3517亿美元增至2028年的171.6461亿美元;预计 2023 年至 2028 年间,该市场的复合年增长率为 6.7%。

CIN 和HR-HPV 治疗市场根据疾病类型、菌株类型、产品、产品类型、最终用户和地理位置进行细分。该报告提供了深入的市场信息和分析,强调了市场驱动因素、趋势和机会等参数,并对各地区领先市场参与者的竞争格局进行了分析。它还包括对主要地区COVID-19大流行的影响的分析。

市场展望

宫颈癌预防的有利举措推动CIN和宫颈癌的预防。 HR-HPV 治疗市场增长

2020 年 8 月,世界卫生组织 (WHO) 制定了消除宫颈癌的全球战略。根据这一战略,世界各国应重点实现并维持每10万妇女中有4例以下的发病率,以消除宫颈癌。为了实现如此低的发病率,各国必须重点关注宫颈癌筛查、治疗和疫苗接种。 Medicare 是一项受欢迎的政府保险计划,为宫颈癌筛查每两年进行一次的子宫颈抹片检查、盆腔检查和临床乳房检查提供承保。

Unitaid 是一家全球卫生机构,致力于为宫颈癌筛查提供创新解决方案。预防、诊断和治疗低收入和中等收入国家重大疾病,启动了预防宫颈癌的新举措。他们的工作重点是扩大关键工具和服务的获取范围,以检测宫颈癌的早期迹象,然后对阳性病例进行治疗。国际药品采购机制支持克林顿健康获取倡议 (CHAI) 和通过二级预防战略扩大宫颈癌消除 (SUCCESS) 项目,这些项目是与 Expertise France、Jhpiego 和国际癌症控制联盟 (UICC) 合作开展的。国际药品采购机制正在与这些合作伙伴以及 14 个低收入和中等收入国家的政府合作,开发一个负担得起且高效的工具包,这可以帮助世界卫生组织实现其消除宫颈癌的目标。国际药品采购机制已投资约 7000 万美元用于创新工具,以检测和治疗生活在资源匮乏环境中的妇女的癌前疾病。在 14 个国家,国际药品采购机制努力克服获取障碍,为国家消除宫颈癌工作奠定基础,在低收入和中等收入国家展示有效的预防模式。

战略视角

< p >在印度,根据资源可用性和合规标准,在各种环境中使用细胞学、联合检测(HPV + 细胞学)、初级 HPV 检测和醋酸目视检查等筛查方法。印度妇产科医生联合会 (FOGSI) 发布了良好临床实践建议 (GCPR),用于在不同资源环境中治疗取得积极结果的女性。 RMNCH+A(代表生殖孕产妇新生儿儿童健康 + 青少年健康 + 青少年)是印度国家卫生使命 (NHM) 战略,鼓励减少家庭规范。该战略包括由经认可的社会健康活动家 (ASHA) 上门提供避孕药具、推迟结婚年龄、提高经期卫生和性卫生意识以及在“Suraksha 诊所”加强对生殖道疾病的治疗。

此类各个卫生组织和政府为预防宫颈癌而采取的举措正在推动 CIN 和宫颈癌的增长。 HR-HPV治疗市场。

基于疾病类型的信息

根据疾病类型,CIN和HR-HPV治疗市场。 HR-HPV治疗市场分为宫颈上皮内瘤变1型(CIN 1)、宫颈上皮内瘤变2型(CIN 2)和宫颈上皮内瘤变3型(CIN 3)。到 2022 年,宫颈上皮内瘤变 3 (CIN 3) 细分市场占据最大的市场份额,预计在预测期内复合年增长率最高。

CIN 和 CIN 3 HR-HPV 治疗市场,按疾病类型:2022-2028

基于毒株类型的信息

根据毒株类型,CIN 和HR-HPV 治疗市场分为 HPV 16、HPV 18 等。 HPV 16 细分市场在 2022 年占据最大的市场份额。HPV 18 细分市场预计在预测期内复合年增长率最高。

基于报价的信息

基于报价,CIN & HR-HPV治疗市场分为诊断方法和治疗方法。 2022年,治疗领域的市场份额更高。然而,诊断方法领域预计在预测期内将出现更高的复合年增长率。此外,诊断方法部分分为HPV检测、巴氏试验、阴道镜检查和活检。 2022年,HPV检测领域在诊断方法市场中占据最大份额。此外,治疗领域分为切除手术和消融技术。到 2022 年,消融技术领域将占据更大的市场份额,预计在预测期内市场复合年增长率将更高。

基于产品类型的信息

基于产品类型,CIN & HR-HPV 治疗市场分为试剂盒和治疗。试剂、仪器和服务。服务细分市场在 2022 年占据最大的市场份额,预计在预测期内复合年增长率最高。

基于最终用户的见解

基于最终用户, CIN& HR-HPV 治疗市场分为医院和医院。诊所、诊断实验室、专业临床实验室等。医院和到 2022 年,诊所细分市场将占据最大的市场份额。诊断实验室细分市场预计在预测期内复合年增长率最高。

CIN 和诊断实验室细分市场的复合年增长率最高。 HR-HPV 治疗市场的参与者采用产品推出和扩张等有机策略来扩大其地理覆盖范围和产品组合。此外,这些增长战略有助于公司增强客户群并扩大产品组合。

  • 2022 年 10 月,Fujirebio Europe 与 Self-screen BV 建立了业务合作关系。分销 PreCursor-M+ 甲基化特异性分子体外诊断 (IVD) 检测(Self-screen BV 的注册商标)。该测试旨在定性检测宫颈癌生物标志物甲基化水平的升高。它可用作 HPV 结果和 ASCUS/LSIL 细胞学结果呈阳性的女性的分诊后续测试。 PreCursor-M+ 检测完善了 Fujirebio 的 HPV 特异性分子检测产品组合。
  • 2021 年 4 月,罗氏的高性能 cobas 6800/8800 系统获得美国 FDA 批准。高性能且完全自动化,可用于 HPV测试。 cobas HPV 检测通过检测宫颈样本中 hrHPV DNA 的存在来识别有患宫颈癌风险的女性。 cobas HPV适用于根据专业医学指南进行常规宫颈癌筛查,包括ASC-US细胞学分类和女性初级HPV筛查,以评估宫颈癌和癌前病变的风险。
    • Fujirebio Europe NV            
    • Qiagen NV          
    • Zilico 有限公司            
    • 雅培实验室
    • Cepheid ;               
    • F.霍夫曼拉罗氏有限公司       
    • INOVIO 制药公司
    • Bioneer 公司             
    • Antiva Biosciences Inc           
    • 赛默飞世尔科技公司
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which region is expected to witness significant demand for CIN and HR-HPV Treatment Market in the coming years?

Global CIN and HR-HPV Treatment Market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. North America held the largest market share of the CIN and HR-HPV Treatment Market in 2021. With several North American market players focusing on research and development activities, the regional market for CIN and HR-HPV Treatment Market is likely to propel in North America region during the forecast period.

Which are the top companies that hold the market share in CIN & HR-HPV Treatment Market?

Abbott and Cepheid are the top two companies that hold huge market shares in the CIN & HR-HPV Treatment Market.

Who are the key players in the CIN & HR-HPV Treatment Market?

The CIN and HR-HPV Treatment Market majorly consists of the players such Fujirebio Europe NV, Qiagen NV, Zilico Ltd, Abbott Laboratories, Cepheid, F. Hoffmann-La Roche Ltd, INOVIO Pharmaceuticals Inc, Bioneer Corp, Antiva Biosciences Inc, and Thermo Fisher Scientific Inc.

Which end user held the largest share in the CIN & HR-HPV Treatment Market?

The hospitals & clinics segment dominated the global CIN and HR-HPV Treatment Market and held the largest market share in 2021.

What is the market CAGR value of CIN and HR-HPV Treatment Market during forecast period?

The CAGR value of the CIN and HR-HPV Treatment Market during the forecasted period of 2022-2028 is 6.7%.

Which disease type leads the CIN & HR-HPV Treatment Market ?

Cervical Intraepithelial Neoplasia 3 segment held the largest share of the market in the global CIN and HR-HPV Treatment Market and held the largest market share of 47.48% in 2022.

What are CIN & HR-HPV?

High-risk HPV is associated with cervical intraepithelial neoplasia (CIN). Persistent infection with high-risk human papillomavirus (HPV) results in invasive cervical cancer. Also, HR-HPV subtypes particularly HPV 16 and HPV 18 causes cervical cancer. The main aim of NHS Cervical Screening Program (NHS CSP) is to reduce the incidence and mortality from cervical cancer through a systematic, quality-assured population-based screening program for people aged 24 to 64.

What are the driving factors for the CIN and HR-HPV Treatment Market across the globe?

Key factors that are driving the growth of this market are Increase in prevalence of human papillomavirus infections and favorable Initiatives for preventing cervical cancer.

The List of Companies - CIN & HR-HPV Treatment Market

  1. Fujirebio Europe NV
  2. Qiagen NV 
  3. Zilico Ltd  
  4. Abbott Laboratories  
  5. Cepheid
  6. F. Hoffmann-La Roche Ltd  
  7. INOVIO Pharmaceuticals Inc
  8. Bioneer Corp  
  9. Antiva Biosciences Inc  
  10. Thermo Fisher Scientific Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports